NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 3 filers reported holding NATERA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099,977 | -56.1% | 25,085 | -50.5% | 0.00% | -66.7% |
| Q2 2023 | $2,506,688 | +172.3% | 50,717 | +207.3% | 0.00% | +200.0% |
| Q1 2023 | $920,649 | -62.9% | 16,505 | -73.8% | 0.00% | -66.7% |
| Q4 2022 | $2,478,380 | +19.3% | 62,903 | +37.2% | 0.00% | 0.0% |
| Q3 2022 | $2,078,000 | +451.2% | 45,834 | +344.8% | 0.00% | +200.0% |
| Q2 2022 | $377,000 | -52.3% | 10,304 | -45.7% | 0.00% | 0.0% |
| Q1 2022 | $791,000 | -69.6% | 18,975 | -31.7% | 0.00% | -50.0% |
| Q4 2021 | $2,601,000 | +72.0% | 27,766 | +104.8% | 0.00% | 0.0% |
| Q3 2021 | $1,512,000 | +7.9% | 13,559 | +9.9% | 0.00% | +100.0% |
| Q2 2021 | $1,401,000 | +26.8% | 12,343 | +11.1% | 0.00% | 0.0% |
| Q4 2020 | $1,105,000 | +26.7% | 11,112 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $872,000 | +15.3% | 11,862 | -21.8% | 0.00% | 0.0% |
| Q2 2020 | $756,000 | +18.5% | 15,169 | -19.9% | 0.00% | 0.0% |
| Q4 2019 | $638,000 | +112.7% | 18,932 | +106.7% | 0.00% | 0.0% |
| Q3 2019 | $300,000 | – | 9,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |